During the past decade, Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center conducted 187 clinical trials. In the 10-year time frame, 187 clinical trials started and 118 clinical trials were completed, i.e. on average, 63.1% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 49 clinical trials were completed. i.e. 68.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" #1 sponsor was "Case Comprehensive Cancer Center" with 349 trials, followed by "Eastern Cooperative Oncology Group" with 28 trials sponsored, "Radiation Therapy Oncology Group" with 19 trials sponsored, "Gynecologic Oncology Group" with 16 trials sponsored and "National Cancer Institute (NCI)" with 16 trials sponsored. Other sponsors include 138 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 297 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 59 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" are "Breast Cancer" (63 trials), "Lymphoma" (44 trials), "Leukemia" (32 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (31 trials) and "Lung Cancer" (29 trials). Many other conditions were trialed in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" are "Drug" (350 trials), "Other" (144 trials), "Procedure" (132 trials), "Biological" (117 trials) and "Radiation" (105 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (37 trials), "laboratory biomarker analysis" (37 trials), "radiation therapy" (37 trials), "filgrastim" (25 trials) and "docetaxel" (23 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center" are 442 trials for "All" genders, 90 trials for "Female" genders and 36 trials for "Male" genders.

Currently, there are 120 active trials in "Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center". 15 are not yet recruiting, 53 are recruiting, 50 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 328 completed trials in Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, 8 suspended trials, and 83 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, 107 "Phase 1" clinical trials were conducted, 229 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 120 trials that are defined as “Not Applicable".